Genzyme Pays $32.5M Criminal Fine For Seprafilm Marketing
Sanofi SA unit Genzyme Corp. agreed Thursday to a roughly $32.5 million fine to resolve criminal charges that it encouraged surgeons to use its Seprafilm surgical product in unapproved ways that...To view the full article, register now.
Already a subscriber? Click here to view full article